Bone Marrow Transplantation Articles & Analysis: Older
7 articles found
In the vibrant realm of cellular biology and regenerative medicine, mesenchymal stem cells (MSCs) hold unparalleled potential for therapeutic applications. Particularly noteworthy are bone marrow mesenchymal stem cells (BM-MSCs), a subtype of MSCs. Their unique properties make them indispensable resources for developing ground-breaking solutions for various medical conditions. Mesenchymal stem ...
As September and Blood Cancer Awareness Month wrap up, we want to reflect on a memorable conversation with Karen Thomas, a woman who received clonoSEQ® testing, and her physician, Dr. Hazma Hashmi, a hematologist-oncologist from the Medical University of South Carolina. At Adaptive, we know our diagnostic tests provide key information that help physicians and patients make treatment ...
HLA, human leukocyte surface antigen, a series of tightly interlocking motifs on the short arm of human chromosome 6, is the central basis for the immune system to recognize and differentiate between allogeneic substances. It is highly polymorphic and corresponds to a complex acquired immune system. It is importantly associated with a variety of autoimmune diseases, tumors, and infectious ...
At an academic conference on Feb 15, U.S. experts announced the world's first female AIDS "cure," making it the third case of HIV infection to be cured. After therapy and withdrawal of antiviral drugs, HIVs were not identified in the patient's body for more than 14 months, indicating that the virus was in complete remission, according to academics. The key to this patient's recovery was a blood ...
Simply put, CAR-T is to transform the patient's immune T cells in vitro by biotechnology, so that they recognize antigens on the surface of tumor cells, and then inject these cells back into the patient to achieve the therapeutic effect of recognizing and killing cancer cells. In 2017, CAR-T therapy was first approved by the FDA for the treatment of blood cancers such as leukemia and lymphoma. ...
Poland has 38 large regional hospitals responsible for hematology and oncology. Genano has delivered a total of over 150 air purifiers to these hospitals. Of the 16 regions in Poland, 13 are using Genano to protect immunocompromised patients. Challenge Polish regional hospitals have recognized the need for protecting patients from infections by providing ultra pure air in patient ...
The issue of hospital acquired infections is a serious problem. According to several sources, three to four million hospital-acquired infections occur annually, with up to 80,000 fatalities. The costs of these infections are estimated to be between $4 billion and $5 billion per year (Air-Treatment Systems for Controlling Hospital acquired Infections, HPAC Engineering, April 2, 2008).Healthcare ...